tirzepatide decision fda on compounded 📢Important Update Tirzepatide! Due to recent FDA regulations, the compounding Did the FDA Ban Compounded

Ozempic is approved for the treatment of type 2 diabetes, with weight loss occurring as a secondary effect

Proactive Wellness Approach Rather than waiting for symptoms to surface, we work with you to build a comprehensive and sustainable health plan that tackles potential concerns before they escalate

By targeting the regulatory mechanisms of hunger and blood sugar, these innovative drugs can facilitate weight loss while preserving the precious muscle mass that is so vital to our overall well-being

Lancet Oncol (2013) 14(3):24956

doi: 10.1515/BC.2009.033 25

Triple Agonist (GLP-1/GIP/Glucagon receptor agonist) Product Overview Retatrutide is a synthetic peptide engineered to simultaneously activate multiple metabolic hormone receptors